Clinical Trial Update: Autonomous Regulatory Monocytes (OPM Cells) for the Treatment of Diabetic Foot in a Single-arm Open-label Clinical Study [EARLY_Phase 1]

View source ↗

Summary

This report outlines an early-phase, single-arm, open-label clinical trial evaluating autonomous regulatory monocytes (OPM Cells) for treating diabetic foot ulc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• OPM Cells (Autonomous Regulatory Monocytes)

Snippet

Sponsor: Shanghai East Hospital | Conditions: Diabetic Foot Ulcer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING